Researchers have developed a tool to determine which breast cancer patients have little risk of their disease recurring. The tool — an algorithm that identifies “gene expression signatures” or biomarkers that can predict low risk tumors with 87-100 percent accuracy in different groups of patients — has the potential to virtually eliminate unnecessary chemotherapy.